Optomed US

Optomed is a Finnish medical technology company and a leading provider of handheld fundus cameras. Optomed combines handheld fundus cameras with software and artificial intelligence with the aim to transform the diagnostic process of blinding eye diseases such as rapidly increasing diabetic retinopathy. Optomed was founded in Oulu, Finland in 2004 by Seppo Kopsala Optomed’s CEO, with the vision to design and produce a smaller and more affordable fundus camera than traditionally used desktop cameras, which would improve the efficiency of the eye screening of diabetics. In the early years, the operations were focused on research and development with a long-term perspective and sales activities were limited. At the beginning of the journey, Optomed developed three early product generations. In 2013, Optomed reached a major milestone when it launched the world’s first handheld fundus camera meeting the fundus camera standard ISO 10940 resolution requirements, Smartscope PRO. In 2017, Optomed launched its fifth handheld fundus camera generation, Optomed Aurora.